The Food and Drug Administration (FDA) recently issued a Notice announcing the availability of an updated final guidance for the industry ...

The government is changing what foods can be branded as “healthy.” It expects basically no one to listen.

At a CVS store in a racially diverse neighborhood in Brooklyn Center, the only devices available to shoppers to measure their ...

The FDA wants the developers of medical devices that rely on AI to disclose more detail about how their devices were ...

From cutting drug costs to reducing overdose deaths, the outgoing president has improved the nation’s health.

In a world where aging gracefully is the ultimate goal for many, the quest for effective anti-aging solutions has led to ...

‘START SCREENING BETTER AT THE DOOR’ — The fallout from the arrest of an undocumented immigrant on gun and drug charges at a ...

The Washington Examiner prides itself on its in-depth, enterprise, and investigative reporting. Here is a summary of our weekly series in 2024.

Despite concerns over cabozantinib's patent expiry, Exelixis projects robust future revenues, with lead pipeline candidate ...

LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...

Around 1,200 people with advanced breast cancer could benefit from a decision by NICE to give the go-ahead to a new treatment ...